• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    DexCom, Inc. (DXCM)

    -NasdaqGS
    56.85 1.11(1.99%) Dec 18, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    DexCom, Inc.
    6340 Sequence Drive
    San Diego, CA 92121
    United States - Map
    Phone: 858-200-0200
    Website: http://www.dexcom.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Instruments & Supplies
    Full Time Employees:646

    Business Summary 

    DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company’s ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. It markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on DexCom, Inc.

    Corporate Governance 
    DexCom, Inc.’s ISS Governance QuickScore as of Dec 1, 2014 is 7. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 9; Compensation: 8.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Terrance H. Gregg , 65
    Chief Exec. Officer and Director
    1.45M2.98M
    Mr. Kevin R. Sayer , 56
    Pres, Chief Operating Officer and Director
    973.00K0.00
    Mr. Jess Roper , 49
    Chief Financial Officer, Principal Accounting Officer and VP
    433.00K589.00K
    Mr. Jorge A. Valdes , 52
    Chief Technical Officer
    717.00K0.00
    Mr. Steven R. Pacelli , 42
    Exec. VP of Strategy & Corp. Devel.
    717.00K1.90M
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders